Aura Biosciences, Inc. Common Stock
$7.655
USD
Last updated on --.
24h volume238.76K
24h highest7.9990 USD
24h lowest7.5950 USD
24h Price movement+0.59%
AURA recent prices
24 Hours
+0.59%+$0.045
30 days
+9.99%+$0.695
60 days
+23.47%+$1.455
90 days
+29.97%+$1.765
Key data
Previous close7.6100 USD
Market cap772.30M USD
Volume238.76K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.0900 USD
Net income (FY)-112.39M USD
Revenue (FY)--
Last report dateMay 11, 2026
About Aura Biosciences, Inc. Common Stock
HeadquartersBOSTON
Employees (FY)113.00
Net income per employee (FY)-994.63K USD
Listed onNasdaq
AURA conversion tables
 |  |
|---|---|
| 0.5 AURA | 3.827 USD |
| 1 AURA | 7.655 USD |
| 5 AURA | 38.27 USD |
| 10 AURA | 76.55 USD |
| |
|---|---|
| 0.5 USD | 0.065317 AURA |
| 1 USD | 0.13063 AURA |
| 5 USD | 0.65317 AURA |
| 10 USD | 1.306 AURA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
AURA is trading at $7.655, +0.59% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AURA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AURA is currently trading at $7.655, +0.59% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AURA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AURA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AURA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AURA's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Aura Biosciences, Inc. Common Stock's market cap is currently 772.30M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume238.76K
24h highest7.9990 USD
24h lowest7.5950 USD
24h Price movement+0.59%
Start trade with AURA Perpetual
Sign up to trade